Stefanie Solomon
Compliance Officer bij AVEO PHARMACEUTICALS, INC.
Oorsprong van het eerstegraads netwerk van Stefanie Solomon
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 12 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Stefanie Solomon via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Veranova LP | Corporate Officer/Principal | ||
| EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer | |
Skadden, Arps, Slate, Meagher & Flom LLP
 Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Skadden, Arps, Slate, Meagher & Flom LLP provides legal advisory services. Its practice areas include mergers and acquisitions, finance, litigation, corporate finance, insurance, tax, labor and employment, political law, private equity, corporate, antitrust, white collar crime, international, regulatory, and legislation. The company was founded by Marshall Skadden, John Slate, and Les Arps in 1948 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Assumption College | College/University | Undergraduate Degree | |
| Boston College | College/University | Undergraduate Degree | |
| Brandeis University | College/University | Doctorate Degree | |
| Clark Atlanta University | College/University | Undergraduate Degree | |
| Florida State University | College/University | Undergraduate Degree | |
| Temple University (Pennsylvania) | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Graduate Degree | |
| Worcester Polytechnic Institute | College/University | Undergraduate Degree | |
| St. Lawrence University | College/University | Undergraduate Degree | |
| ARGENX SE | Pharmaceuticals: Other | Corporate Officer/Principal | |
| IMV INC. | Biotechnology | Chairman | |
| VERASTEM, INC. | Biotechnology | Corporate Officer/Principal | |
| Boston University School of Law | College/University | Graduate Degree | |
| Mendoza College of Business | College/University | Masters Business Admin | |
| HORIZON DISCOVERY GROUP PLC | Medical Specialties | Chief Operating Officer | |
| University of San Francisco School of Management | College/University | Masters Business Admin | |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Operating Officer | |
Enzyvant Therapeutics, Inc.
 Enzyvant Therapeutics, Inc. BiotechnologyHealth Technology Enzyvant Therapeutics, Inc. develops biopharmaceutical products. It focuses on developing transformative therapies for rare diseases with high unmet needs. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer |
Statistieken
Internationaal
| Verenigde Staten | 29 |
| Japan | 2 |
| Brazilië | 2 |
| Nederland | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 13 |
| Commercial Services | 2 |
Operationeel
| Corporate Officer/Principal | 16 |
| Chief Operating Officer | 7 |
| Undergraduate Degree | 7 |
| Director/Board Member | 4 |
| General Counsel | 3 |
Sterkste connecties
- Beurs
- Insiders
- Stefanie Solomon
- Bedrijfsconnecties